Skip to content Skip to navigation

Drug Testing

Ethics Survey: Behavioral health leaders examine industry conduct

March 1, 2017  |  Julie Miller, Editor in Chief
article

It’s difficult to quantify the prevalence of unethical practices in behavioral health, but most agree it's more a case of criminal enterprise than treatment centers gone bad. See the survey results with expert analysis.

ASAM seeks input on appropriate drug testing

February 10, 2017  |  Tom Valentino, Senior Editor
article

ASAM is accepting public comment on a drug testing appropriateness document that is being developed to provide guidance on drug testing in diagnosis, treatment and promotion of recovery from addiction.

Florida poised to turn the corner on unethical practices in 2017

January 4, 2017  |  Gary A. Enos
article

There are signs that Florida legislators might finally enact tough measures to curb unethical behavior among notorious addiction treatment and sober home operators.

Kratom research sorely needed for clinical, policy decisions

October 13, 2016  |  Julie Miller, Editor in Chief
article

In response to advocacy groups and congressional leaders, the Drug Enforcement Administration halted its attempt to place kratom on the list of Schedule I drugs, however, experts recommend more research on its pharmacology moving forward.

Claims study quantifies growing impact of opioid crisis

September 13, 2016  |  Julie Miller, Editor in Chief
article

Commercial health insurers paid treatment centers and other providers $445.7 million to treat plan members’ opioid dependence and abuse in 2015, demonstrating a 1,375% spending increase over five years.

Insurer drops drug screen requirement for hep C coverage

September 13, 2016  |  Tom Valentino, Senior Editor
news

As part of a $300 million settlement, UnitedHealthcare will no longer require policyholders to demonstrate abstinence from drugs and alcohol for six months before receiving coverage for a costly hepatitis C medication.

UnitedHealth names labs, treatment centers in federal fraud case

May 2, 2016  |  Julie Miller, Editor in Chief
article

UnitedHealth and its Florida affiliate filed a $50 million federal lawsuit against several testing labs, treatment centers and individuals, alleging financial kickbacks, fraud and other complaints.

New group funds patient copays for treatment

April 13, 2016  |  Julie Miller, Editor in Chief
article

The new not-for-profit Insured Consumer Access Network (ICAN) will provide scholarships for patients' out-of-pocket costs for treatment within a network of ethical providers.

Growth trend continued in Q4 of 2015

February 26, 2016  |  Julie Miller, Editor in Chief
article

Here's a roundup of 2015 earnings reports for Acadia, American Addiction Centers and Universal Health Services. Acquisitions and new growth after a potential change to the IMD exclusion were key issues.

Insurance warriors fight for coverage

December 23, 2015  |  Jill Sederstrom
article

With increased insurance coverage, more providers will encounter the frustration of meeting the preauthorization demands of payers. The key is to fight like an insurance warrior.

Payers open to 5 year treatment plan

November 2, 2015  |  Julie Miller, Editor in Chief
article

Payers want to know who the best addiction treatment providers are and how to get the best return. The Independent Coalition of Treatment Providers aims to answer those questions.

BREAKING: Calloway Labs will close this month

October 8, 2015  |  Gary A. Enos. Contributing Editor
news

Drug testing company Calloway Laboratories, which in recent years had been embroiled in controversies over improper government payments, is citing "unforeseen circumstances" in its decision to cease operation on Oct. 16.

Pages

Subscribe to Drug Testing